← Back to headlines
F.D.A. Faces Upset Over Denials of New Drugs
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.
5 Mar, 10:01 — 5 Mar, 10:01
